Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid's broad test portfolio spans respiratory infections, blood virology, women's and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company's solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. For more information, visit http://www.cepheid.com. Cepheid is proud to be a part of Danaher. Danaher's science and technology leadership puts Cepheid's solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher's other businesses across Biotechnology, Diagnostics, and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.
解锁市场时间线与信号动态
新增 营销与公关 活动 — 刚出现 8 个新信号。
该公司进入各个市场的顺序 — 从最早到最新
Field Applications Engineer - Molecular Diagnostics (IVD)
10 active postings
注册以查看完整信号动态
Cepheid 的国际扩张与竞争对手的对比情况
Cepheid你条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
 Cepheid你 | 9 | 3 | +1200% | 14 | 30 |
Lead Biostatistician, Global Quality, Regulatory, Clinical Affairs
查看职位Bengaluru East, Karnataka, India · 上周
Lead Computer Integration Engineer
查看职位Penang, Penang, Malaysia · 3周前
Supplier Development & CM Transfer Engineer
查看职位Penang, Penang, Malaysia · 3周前
☝️ What if every treatment decision started with better diagnostics?🎤 In this Cepheid Talks podcast episode, Dr. Ephraim Tsalik shares his perspective on the evolving role of diagnostics in clinical decision-making and antimicrobial resistance (AMR). 💫 From advancing innovation to enabling more precise, timely care, this conversation explores how diagnostics can help shape better outcomes for both clinicians and patients.Tune in now: https://ow.ly/44zi50Z7oxA ...
进行中
C. difficile Is Not Just Another GI Pathogen — Why Testing Strategy MattersHigh rates of asymptomatic colonization mean that how we test for C. difficile directly impacts diagnosis, treatment decisions, antimicrobial exposure, and stewardship outcomes.🎥 Now available on demand:Watch our global expert webinar to explore:• Colonization vs. true infection• The clinical impact of testing strategy• Diagnostic & antimicrobial stewardship• Practical insights for clinicians and labs👉 Access the on‑dem ...
已结束Hi %FIRSTNAME%At ESCMID Global 2026, experts explored how diagnostic stewardship, smart molecular panels, and the evolving role of metagenomics are shaping more confident clinical decision‑makingIf you couldn’t attend in Munich, you haven’t missed your opportunity. Catch up on the topics belowAccess the recorded symposium and catch up on your own schedule.
已结束解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 Cepheid 的业务、市场和增长信号的快速解答。
